Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Cheung

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Cancer|April 17, 2015
Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysisAnca Prica, Kelvin Chan, Matthew Cheung
International Journal of Pharmaceutical Compounding|January 27, 2021
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving TabletsMatthew Cheung, Fang Zhao, Vivek S Dave
Currents in Pharmacy Teaching & Learning|July 23, 2023
A preceptor development program using an interactive board gameJanet Heather Cooley, Suzanne Larson, Matthew Cheung
Surgery|September 4, 2018
Predicting burn patient mortality with electronic medical recordsMatthew Cheung, Adrienne N Cobb, Paul C Kuo
Journal of Palliative Medicine|December 22, 2020
Days Spent at Home before Death from Cancer for Immigrants and Long-Term Residents in Ontario, CanadaSarah Engelhart, Matthew Cheung, Ruth Croxford, et al.
Blood Advances|November 29, 2023
A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AMLMithunan Ravindran, Lee Mozessohn, Matthew Cheung, et al.
Case Reports in Radiology|June 1, 2018
Rosai-Dorfman Disease: Rare Pulmonary Involvement Mimicking Pulmonary Langerhans Cell Histiocytosis and Review of the LiteratureRashid Al Umairi, Danielle Blunt, Wedad Hana, et al.
JAMA Oncology|May 17, 2019
Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical TrialsRonak Saluja, Louis Everest, Sierra Cheng, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology DrugsRonak Saluja, Tina Jiao, Liza Koshy, et al.
Blood Advances|June 21, 2021
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patientsAbi Vijenthira, Inna Gong, Stephen D Betschel, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Cancer|April 17, 2015
Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysisAnca Prica, Kelvin Chan, Matthew Cheung
International Journal of Pharmaceutical Compounding|January 27, 2021
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving TabletsMatthew Cheung, Fang Zhao, Vivek S Dave
Currents in Pharmacy Teaching & Learning|July 23, 2023
A preceptor development program using an interactive board gameJanet Heather Cooley, Suzanne Larson, Matthew Cheung
Surgery|September 4, 2018
Predicting burn patient mortality with electronic medical recordsMatthew Cheung, Adrienne N Cobb, Paul C Kuo
Journal of Palliative Medicine|December 22, 2020
Days Spent at Home before Death from Cancer for Immigrants and Long-Term Residents in Ontario, CanadaSarah Engelhart, Matthew Cheung, Ruth Croxford, et al.
Blood Advances|November 29, 2023
A Markov analysis of azacitidine and venetoclax vs induction chemotherapy for medically fit patients with AMLMithunan Ravindran, Lee Mozessohn, Matthew Cheung, et al.
Case Reports in Radiology|June 1, 2018
Rosai-Dorfman Disease: Rare Pulmonary Involvement Mimicking Pulmonary Langerhans Cell Histiocytosis and Review of the LiteratureRashid Al Umairi, Danielle Blunt, Wedad Hana, et al.
JAMA Oncology|May 17, 2019
Assessment of Whether the American Society of Clinical Oncology's Value Framework and the European Society for Medical Oncology's Magnitude of Clinical Benefit Scale Measure Absolute or Relative Clinical Survival Benefit: An Analysis of Randomized Clinical TrialsRonak Saluja, Louis Everest, Sierra Cheng, et al.
Current Oncology (Toronto, Ont.)|January 27, 2021
Comparing Manufacturer Submitted and Pan-Canadian Oncology Drug Review Reanalysed Incremental Cost-Effectiveness Ratios for Novel Oncology DrugsRonak Saluja, Tina Jiao, Liza Koshy, et al.
Blood Advances|June 21, 2021
Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patientsAbi Vijenthira, Inna Gong, Stephen D Betschel, et al.
Pageof 6